Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 486

1.

Working together to deliver stratified medicine research effectively.

Attar SG, Poustie VJ, Smye SW, Beety JM, Hawcutt DB, Littlewood S, Oni L, Pirmohamed M, Beresford MW.

Br Med Bull. 2019 Feb 7. doi: 10.1093/bmb/ldz003. [Epub ahead of print]

PMID:
30753334
2.

Genome-wide association study of inhaled corticosteroid response in admixed children with asthma.

Hernandez-Pacheco N, Farzan N, Francis B, Karimi L, Repnik K, Vijverberg SJ, Soares P, Schieck M, Gorenjak M, Forno E, Eng C, S Oh S, Pérez-Méndez L, Berce V, Tavendale R, Samedy LA, Hunstman S, Hu D, Meade K, Farber HJ, Avila PC, Serebrisky D, Thyne SM, Brigino-Buenaventura E, Rodriguez-Cintron W, Sen S, Kumar R, Lenoir M, Rodriguez-Santana JR, Celedón JC, Mukhopadhyay S, Potočnik U, Pirmohamed M, Verhamme KM, Kabesch M, Palmer CNA, Hawcutt DB, Flores C, van der Zee AHM, Burchard EG, Pino-Yanes M.

Clin Exp Allergy. 2019 Jan 29. doi: 10.1111/cea.13354. [Epub ahead of print]

PMID:
30697902
3.

Nilotinib-induced metabolic dysfunction: insights from a translational study using in vitro adipocyte models and patient cohorts.

Sadiq S, Owen E, Foster T, Knight K, Wang L, Pirmohamed M, Clark RE, Pushpakom S.

Leukemia. 2019 Jan 28. doi: 10.1038/s41375-018-0337-0. [Epub ahead of print] No abstract available.

PMID:
30692595
4.

Software for Dosage Individualization of Voriconazole: a Prospective Clinical Study.

Hope W, Johnstone G, Cicconi S, Felton T, Goodwin J, Whalley S, Santoyo-Castelazo A, Ramos-Martin V, Lestner J, Credidio L, Dane A, Carr DF, Pirmohamed M, Salim R, Neely M.

Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02353-18. doi: 10.1128/AAC.02353-18. [Epub ahead of print]

5.

A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury.

Cirulli ET, Nicoletti P, Abramson K, Andrade RJ, Bjornsson ES, Chalasani N, Fontana RJ, Hallberg P, Li YJ, Lucena MI, Long N, Molokhia M, Nelson MR, Odin JA, Pirmohamed M, Rafnar T, Serrano J, Stefansson K, Stolz A, Daly AK, Aithal GP, Watkins PB; Drug-Induced Liver Injury Network (DILIN) investigators and International DILI consortium (iDILIC).

Gastroenterology. 2019 Jan 18. pii: S0016-5085(19)30094-0. doi: 10.1053/j.gastro.2019.01.034. [Epub ahead of print]

PMID:
30664875
6.

Drug-induced injury due to flucloxacillin: relevance of multiple HLA alleles.

Nicoletti P, Aithal GP, Chamberlain TC, Coulthard S, Alshabeeb M, Grove JI, Andrade RJ, Bjornsson E, Dillon JF, Hallberg P, Lucena MI, Maitland van der Zee AH, Martin JH, Molokhia M, Pirmohamed M, Wadelius M, Shen Y, Nelson MR, Daly AK; International Drug-induced Liver Injury consortium (iDILIC).

Clin Pharmacol Ther. 2019 Jan 19. doi: 10.1002/cpt.1375. [Epub ahead of print]

PMID:
30661239
7.

Serum and blister-fluid elevation and decreased epidermal content of HMGB1 protein in drug-induced Stevens Johnson syndrome/toxic epidermal necrolysis.

Carr DF, Wang CW, Bellón T, Ressel L, Nwikue G, Shrivastava V, Bergfeld W, Jorgensen AL, Chung WH, Pirmohamed M.

Br J Dermatol. 2019 Jan 5. doi: 10.1111/bjd.17610. [Epub ahead of print]

PMID:
30613954
8.

What are the social predictors of accident and emergency attendance in disadvantaged neighbourhoods? Results from a cross-sectional household health survey in the north west of England.

Giebel C, McIntyre JC, Daras K, Gabbay M, Downing J, Pirmohamed M, Walker F, Sawicki W, Alfirevic A, Barr B.

BMJ Open. 2019 Jan 6;9(1):e022820. doi: 10.1136/bmjopen-2018-022820.

9.

Controversies in drug allergy: Testing for delayed reactions.

Phillips EJ, Bigliardi P, Bircher AJ, Broyles A, Chang YS, Chung WH, Lehloenya R, Mockenhaupt M, Peter J, Pirmohamed M, Roujeau JC, Shear NH, Tanno LK, Trubiano J, Valluzzi R, Barbaud A.

J Allergy Clin Immunol. 2019 Jan;143(1):66-73. doi: 10.1016/j.jaci.2018.10.030. Epub 2018 Dec 17. Review.

PMID:
30573342
10.

Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals.

Danese E, Raimondi S, Montagnana M, Tagetti A, Langaee T, Borgiani P, Ciccacci C, Carcas AJ, Borobia AM, Tong HY, Dávila-Fajardo C, Rodrigues Botton M, Bourgeois S, Deloukas P, Caldwell MD, Burmester JK, Berg RL, Cavallari LH, Drozda K, Huang M, Zhao LZ, Cen HJ, Gonzalez-Conejero R, Roldan V, Nakamura Y, Mushiroda T, Gong IY, Kim RB, Hirai K, Itoh K, Isaza C, Beltrán L, Jiménez-Varo E, Cañadas-Garre M, Giontella A, Kringen MK, Haug KBF, Gwak HS, Lee KE, Minuz P, Lee MTM, Lubitz SA, Scott S, Mazzaccara C, Sacchetti L, Genç E, Özer M, Pathare A, Krishnamoorthy R, Paldi A, Siguret V, Loriot MA, Kutala VK, Suarez-Kurtz G, Perini J, Denny JC, Ramirez AH, Mittal B, Rathore SS, Sagreiya H, Altman R, Shahin MHA, Khalifa SI, Limdi NA, Rivers C, Shendre A, Dillon C, Suriapranata IM, Zhou HH, Tan SL, Tatarunas V, Lesauskaite V, Zhang Y, Maitland-van der Zee AH, Verhoef TI, de Boer A, Taljaard M, Zambon CF, Pengo V, Zhang JE, Pirmohamed M, Johnson JA, Fava C.

Clin Pharmacol Ther. 2018 Dec 2. doi: 10.1002/cpt.1323. [Epub ahead of print]

PMID:
30506689
11.

Cost-Effectiveness of Panel Tests for Multiple Pharmacogenes Associated With Adverse Drug Reactions: An Evaluation Framework.

Plumpton CO, Pirmohamed M, Hughes DA.

Clin Pharmacol Ther. 2018 Nov 22. doi: 10.1002/cpt.1312. [Epub ahead of print]

PMID:
30466189
12.

Drug repurposing: progress, challenges and recommendations.

Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, Norris A, Sanseau P, Cavalla D, Pirmohamed M.

Nat Rev Drug Discov. 2018 Oct 12. doi: 10.1038/nrd.2018.168. [Epub ahead of print] Review.

PMID:
30310233
13.

Nonmedical prescriber experiences of training and competence to report adverse drug reactions in the UK.

Thompson A, Randall C, Howard J, Barker C, Bowden D, Mooney P, Munyika A, Smith S, Pirmohamed M.

J Clin Pharm Ther. 2019 Feb;44(1):78-83. doi: 10.1111/jcpt.12756. Epub 2018 Sep 11.

PMID:
30206951
14.

Trastuzumab uptake in HER2-positive breast cancer patients: a systematic review and meta-analysis of observational studies.

Martin AP, Downing J, Cochrane M, Collins B, Francis B, Haycox A, Alfirevic A, Pirmohamed M.

Crit Rev Oncol Hematol. 2018 Oct;130:92-107. doi: 10.1016/j.critrevonc.2018.07.012. Epub 2018 Aug 3. Review.

PMID:
30196916
15.

A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for Psoriasis.

Foulkes AC, Watson DS, Carr DF, Kenny JG, Slidel T, Parslew R, Pirmohamed M; PSORT Consortium, Anders S, Reynolds NJ, Griffiths CEM, Warren RB, Barnes MR.

J Invest Dermatol. 2019 Jan;139(1):100-107. doi: 10.1016/j.jid.2018.04.041. Epub 2018 Jul 17.

PMID:
30030151
16.

Development, validation and application of a novel HPLC-MS/MS method for the quantification of atorvastatin, bisoprolol and clopidogrel in a large cardiovascular patient cohort.

Turner RM, Fontana V, Bayliss M, Whalley S, Santoyo Castelazo A, Pirmohamed M.

J Pharm Biomed Anal. 2018 Sep 10;159:272-281. doi: 10.1016/j.jpba.2018.06.062. Epub 2018 Jul 3.

17.

Warfarin: The End or the End of One Size Fits All Therapy?

Pirmohamed M.

J Pers Med. 2018 Jun 28;8(3). pii: E22. doi: 10.3390/jpm8030022. Review.

18.

New uses for old drugs.

Pantziarka P, Pirmohamed M, Mirza N.

BMJ. 2018 Jun 26;361:k2701. doi: 10.1136/bmj.k2701. No abstract available.

PMID:
29945952
19.

Cellular Uptake of the Atypical Antipsychotic Clozapine Is a Carrier-Mediated Process.

Dickens D, Rädisch S, Chiduza GN, Giannoudis A, Cross MJ, Malik H, Schaeffeler E, Sison-Young RL, Wilkinson EL, Goldring CE, Schwab M, Pirmohamed M, Nies AT.

Mol Pharm. 2018 Aug 6;15(8):3557-3572. doi: 10.1021/acs.molpharmaceut.8b00547. Epub 2018 Jul 10.

PMID:
29944835
20.

Genetic and nongenetic factors that may predispose individuals to allergic drug reactions.

Gibson A, Ogese M, Pirmohamed M.

Curr Opin Allergy Clin Immunol. 2018 Aug;18(4):325-332. doi: 10.1097/ACI.0000000000000459.

PMID:
29889140
21.

17q21 variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroids use.

Farzan N, Vijverberg SJ, Hernandez-Pacheco N, Bel EHD, Berce V, Bønnelykke K, Bisgaard H, Burchard EG, Canino G, Celedón JC, Chew FT, Chiang WC, Cloutier MM, Forno E, Francis B, Hawcutt DB, Herrera-Luis E, Kabesch M, Karimi L, Melén E, Mukhopadhyay S, Merid SK, Palmer CN, Pino-Yanes M, Pirmohamed M, Potočnik U, Repnik K, Schieck M, Sevelsted A, Sio YY, Smyth RL, Soares P, Söderhäll C, Tantisira KG, Tavendale R, Tse SM, Turner S, Verhamme KM, Maitland-van der Zee AH.

Allergy. 2018 Oct;73(10):2083-2088. doi: 10.1111/all.13499. Epub 2018 Jul 9. No abstract available.

22.

Adrenal suppression with inhaled corticosteroids: the seed and the soil - Authors' reply.

Hawcutt DB, Francis B, Pirmohamed M.

Lancet Respir Med. 2018 Jun;6(6):e20. doi: 10.1016/S2213-2600(18)30149-8. No abstract available.

PMID:
29856322
23.

Pharmacogenetics of Adverse Drug Reactions.

Osanlou O, Pirmohamed M, Daly AK.

Adv Pharmacol. 2018;83:155-190. doi: 10.1016/bs.apha.2018.03.002.

PMID:
29801574
24.

Causality Patterns for Detecting Adverse Drug Reactions From Social Media: Text Mining Approach.

Bollegala D, Maskell S, Sloane R, Hajne J, Pirmohamed M.

JMIR Public Health Surveill. 2018 May 9;4(2):e51. doi: 10.2196/publichealth.8214.

25.

TEMPORARY REMOVAL: Reference intervals for putative biomarkers of drug-induced liver injury and liver regeneration in healthy human volunteers.

Francis B, Clarke JI, Walker LE, Brillant N, Jorgensen AL, Park BK, Pirmohamed M, Antoine DJ.

J Hepatol. 2018 May 3. pii: S0168-8278(18)32042-7. doi: 10.1016/j.jhep.2018.04.024. [Epub ahead of print]

PMID:
29729369
26.

Letter to the Editor: Response to Costa et al.

Thompson A, Owens L, Richardson P, Pirmohamed M.

Eur Neuropsychopharmacol. 2018 May;28(5):658. doi: 10.1016/j.euroneuro.2018.03.002. Epub 2018 Apr 12. No abstract available.

PMID:
29655506
27.

Urinary Biomarkers of Aminoglycoside-Induced Nephrotoxicity in Cystic Fibrosis: Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin.

McWilliam SJ, Antoine DJ, Jorgensen AL, Smyth RL, Pirmohamed M.

Sci Rep. 2018 Mar 23;8(1):5094. doi: 10.1038/s41598-018-23466-4.

28.

Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study.

Hawcutt DB, Francis B, Carr DF, Jorgensen AL, Yin P, Wallin N, O'Hara N, Zhang EJ, Bloch KM, Ganguli A, Thompson B, McEvoy L, Peak M, Crawford AA, Walker BR, Blair JC, Couriel J, Smyth RL, Pirmohamed M.

Lancet Respir Med. 2018 Jun;6(6):442-450. doi: 10.1016/S2213-2600(18)30058-4. Epub 2018 Mar 15.

29.

Direct oral anticoagulants versus warfarin: is new always better than the old?

Burn J, Pirmohamed M.

Open Heart. 2018 Feb 7;5(1):e000712. doi: 10.1136/openhrt-2017-000712. eCollection 2018. Review.

30.

Telmisartan reverses antiretroviral-induced adipocyte toxicity and insulin resistance in vitro.

Pushpakom SP, Adaikalakoteswari A, Owen A, Back DJ, Tripathi G, Kumar S, McTernan P, Pirmohamed M.

Diab Vasc Dis Res. 2018 May;15(3):233-242. doi: 10.1177/1479164118757924. Epub 2018 Feb 21.

31.

Application of in Vitro T Cell Assay Using Human Leukocyte Antigen-Typed Healthy Donors for the Assessment of Drug Immunogenicity.

Usui T, Faulkner L, Farrell J, French NS, Alfirevic A, Pirmohamed M, Park BK, Naisbitt DJ.

Chem Res Toxicol. 2018 Mar 19;31(3):165-167. doi: 10.1021/acs.chemrestox.8b00030. Epub 2018 Feb 14.

PMID:
29436218
32.

Correction: The Effect of Inhibitory Signals on the Priming of Drug Hapten-Specific T Cells That Express Distinct Vβ Receptors.

Gibson A, Faulkner L, Lichtenfels M, Ogese M, Al-Attar Z, Alfirevic A, Esser PR, Martin SF, Pirmohamed M, Park BK, Naisbitt DJ.

J Immunol. 2018 Mar 1;200(5):1951. doi: 10.4049/jimmunol.1800019. Epub 2018 Feb 2. No abstract available.

PMID:
29427416
33.

Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update.

Phillips EJ, Sukasem C, Whirl-Carrillo M, Müller DJ, Dunnenberger HM, Chantratita W, Goldspiel B, Chen YT, Carleton BC, George AL Jr, Mushiroda T, Klein T, Gammal RS, Pirmohamed M.

Clin Pharmacol Ther. 2018 Apr;103(4):574-581. doi: 10.1002/cpt.1004. Epub 2018 Feb 2.

PMID:
29392710
34.

Nucleic acid based therapies: developing frontier for precision medicine.

Pirmohamed M.

BMJ. 2018 Jan 23;360:k223. doi: 10.1136/bmj.k223. No abstract available.

PMID:
29363539
35.

The prescribable drugs with efficacy in experimental epilepsies (PDE3) database for drug repurposing research in epilepsy.

Sivapalarajah S, Krishnakumar M, Bickerstaffe H, Chan Y, Clarkson J, Hampden-Martin A, Mirza A, Tanti M, Marson A, Pirmohamed M, Mirza N.

Epilepsia. 2018 Feb;59(2):492-501. doi: 10.1111/epi.13994. Epub 2018 Jan 17.

36.

SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation.

White KD, Abe R, Ardern-Jones M, Beachkofsky T, Bouchard C, Carleton B, Chodosh J, Cibotti R, Davis R, Denny JC, Dodiuk-Gad RP, Ergen EN, Goldman JL, Holmes JH 4th, Hung SI, Lacouture ME, Lehloenya RJ, Mallal S, Manolio TA, Micheletti RG, Mitchell CM, Mockenhaupt M, Ostrov DA, Pavlos R, Pirmohamed M, Pope E, Redwood A, Rosenbach M, Rosenblum MD, Roujeau JC, Saavedra AP, Saeed HN, Struewing JP, Sueki H, Sukasem C, Sung C, Trubiano JA, Weintraub J, Wheatley LM, Williams KB, Worley B, Chung WH, Shear NH, Phillips EJ.

J Allergy Clin Immunol Pract. 2018 Jan - Feb;6(1):38-69. doi: 10.1016/j.jaip.2017.11.023. Review.

37.

Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients.

McCormack M, Gui H, Ingason A, Speed D, Wright GEB, Zhang EJ, Secolin R, Yasuda C, Kwok M, Wolking S, Becker F, Rau S, Avbersek A, Heggeli K, Leu C, Depondt C, Sills GJ, Marson AG, Auce P, Brodie MJ, Francis B, Johnson MR, Koeleman BPC, Striano P, Coppola A, Zara F, Kunz WS, Sander JW, Lerche H, Klein KM, Weckhuysen S, Krenn M, Gudmundsson LJ, Stefánsson K, Krause R, Shear N, Ross CJD, Delanty N; EPIGEN Consortium;, Pirmohamed M, Carleton BC; Canadian Pharmacogenomics Network for Drug Safety;, Cendes F, Lopes-Cendes I, Liao WP, O'Brien TJ, Sisodiya SM; EpiPGX Consortium;, Cherny S, Kwan P, Baum L; International League Against Epilepsy Consortium on Complex Epilepsies;, Cavalleri GL.

Neurology. 2018 Jan 23;90(4):e332-e341. doi: 10.1212/WNL.0000000000004853. Epub 2017 Dec 29. Erratum in: Neurology. 2018 Oct 16;91(16):765.

38.

Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosis.

Whitfield JB, Masson S, Liangpunsakul S, Hyman J, Mueller S, Aithal G, Eyer F, Gleeson D, Thompson A, Stickel F, Soyka M, Daly AK, Cordell HJ, Liang T, Foroud T, Lumeng L, Pirmohamed M, Nalpas B, Bence C, Jacquet JM, Louvet A, Moirand R, Nahon P, Naveau S, Perney P, Podevin P, Haber PS, Seitz HK, Day CP, Mathurin P, Morgan TM, Seth D; GenomALC Consortium.

Alcohol. 2018 Feb;66:1-7. doi: 10.1016/j.alcohol.2017.07.006. Epub 2017 Sep 23.

39.

Zoonotic Transfer of Clostridium difficile Harboring Antimicrobial Resistance between Farm Animals and Humans.

Knetsch CW, Kumar N, Forster SC, Connor TR, Browne HP, Harmanus C, Sanders IM, Harris SR, Turner L, Morris T, Perry M, Miyajima F, Roberts P, Pirmohamed M, Songer JG, Weese JS, Indra A, Corver J, Rupnik M, Wren BW, Riley TV, Kuijper EJ, Lawley TD.

J Clin Microbiol. 2018 Feb 22;56(3). pii: e01384-17. doi: 10.1128/JCM.01384-17. Print 2018 Mar.

40.

The molecular genetics of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis.

Cliff J, Jorgensen AL, Lord R, Azam F, Cossar L, Carr DF, Pirmohamed M.

Crit Rev Oncol Hematol. 2017 Dec;120:127-140. doi: 10.1016/j.critrevonc.2017.09.009. Epub 2017 Sep 25. Review.

PMID:
29198326
41.

Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies.

Dear JW, Clarke JI, Francis B, Allen L, Wraight J, Shen J, Dargan PI, Wood D, Cooper J, Thomas SHL, Jorgensen AL, Pirmohamed M, Park BK, Antoine DJ.

Lancet Gastroenterol Hepatol. 2018 Feb;3(2):104-113. doi: 10.1016/S2468-1253(17)30266-2. Epub 2017 Nov 14.

42.

Repurposing Statins for Renal Protection: Is It a Class Effect?

McWilliam SJ, Antoine DJ, Pirmohamed M.

Clin Transl Sci. 2018 Mar;11(2):100-102. doi: 10.1111/cts.12521. Epub 2017 Nov 15. No abstract available.

43.

Research Directions in Genetic Predispositions to Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis.

Manolio TA, Hutter CM, Avigan M, Cibotti R, Davis RL, Denny JC, Grenade L, Wheatley LM, Carrington MN, Chantratita W, Chung WH, Dalton AD, Hung SI, Lee MTM, Leeder JS, Lertora JJL, Mahasirimongkol S, McLeod HL, Mockenhaupt M, Pacanowski M, Phillips EJ, Pinheiro S, Pirmohamed M, Sung C, Suwankesawong W, Trepanier L, Tumminia SJ, Veenstra D, Yuliwulandari R, Shear NH.

Clin Pharmacol Ther. 2018 Mar;103(3):390-394. doi: 10.1002/cpt.890. Epub 2017 Nov 6.

PMID:
29105735
44.

An assessment of the impact of pharmacogenomics on health disparities: a systematic literature review.

Martin A, Downing J, Maden M, Fleeman N, Alfirevic A, Haycox A, Pirmohamed M.

Pharmacogenomics. 2017 Nov;18(16):1541-1550. doi: 10.2217/pgs-2017-0076. Epub 2017 Nov 2. Review.

45.

How important is aspirin adherence when evaluating effectiveness of low-dose aspirin?

Navaratnam K, Alfirevic Z, Pirmohamed M, Alfirevic A.

Eur J Obstet Gynecol Reprod Biol. 2017 Dec;219:1-9. doi: 10.1016/j.ejogrb.2017.10.004. Epub 2017 Oct 3. Review.

PMID:
29024912
46.

A common missense variant of LILRB5 is associated with statin intolerance and myalgia.

K Siddiqui M, Maroteau C, Veluchamy A, Tornio A, Tavendale R, Carr F, Abelega NU, Carr D, Bloch K, Hallberg P, Yue QY, Pearson ER, Colhoun HM, Morris AD, Dow E, George J, Pirmohamed M, Ridker PM, Doney ASF, Alfirevic A, Wadelius M, Maitland-van der Zee AH, Chasman DI, Palmer CNA; PREDICTION-ADR Consortium.

Eur Heart J. 2017 Dec 21;38(48):3569-3575. doi: 10.1093/eurheartj/ehx467.

47.

Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout.

Plumpton CO, Alfirevic A, Pirmohamed M, Hughes DA.

Rheumatology (Oxford). 2017 Oct 1;56(10):1729-1739. doi: 10.1093/rheumatology/kex253. Review.

PMID:
28957559
48.

Biomarkers of adverse drug reactions.

Carr DF, Pirmohamed M.

Exp Biol Med (Maywood). 2018 Feb;243(3):291-299. doi: 10.1177/1535370217733425. Epub 2017 Sep 26. Review.

49.

Systematic review: Baclofen dosing protocols for alcohol use disorders used in observational studies.

Thompson A, Owens L, Richardson P, Pirmohamed M.

Eur Neuropsychopharmacol. 2017 Nov;27(11):1077-1089. doi: 10.1016/j.euroneuro.2017.08.434. Epub 2017 Sep 20.

PMID:
28939163
50.

Renal function monitoring in heart failure - what is the optimal frequency? A narrative review.

Al-Naher A, Wright D, Devonald MAJ, Pirmohamed M.

Br J Clin Pharmacol. 2018 Jan;84(1):5-17. doi: 10.1111/bcp.13434. Epub 2017 Oct 22. Review.

Supplemental Content

Loading ...
Support Center